Clinical Trial 40207


Garden Grove, CA 92845

Study Summary:

A Phase 2, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate
Efficacy, Safety, Tolerability, and Pharmacokinetics of 3 Dose levels of TAK-831 in Adjunctive
Treatment of Adult Subjects With Negative Symptoms of Schizophrenia

Qualified Participants Must:

• 1. The subject is male or female and aged 18 to 50 years
• 2. The subject has a current diagnosis of schizophrenia

Qualified Participants May Receive:

Compensation for time and travel 

Research Site Profile

View Clinic Profile

Study is Available At:

CNS Network
12772 Valley View Ave, Suite 3
Garden Grove, CA 92845
View Clinic Location


If you would like to get the phone number or be contacted by the clinical trial representative and live within 50 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.